本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Astria Therapeutics Inc

4.04
+0.06001.51%
盤後4.040.00000.00%17:15 EDT
成交量:20.23萬
成交額:81.68萬
市值:2.28億
市盈率:-2.41
高:4.18
開:3.97
低:3.93
收:3.98
資料載入中...
2024/03/04

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/12

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/05

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/31

重要事件披露

Form 8-K - Current report
2024/01/30

重要事件披露

Form 8-K - Current report
2024/01/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/16

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/05

重要事件披露

Form 8-K - Current report
2024/01/03

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/29

SEC問詢函

Form CORRESP - Correspondence
2023/12/29

SEC問詢函

Form CORRESP - Correspondence
2023/12/20

重要事件披露

Form 8-K - Current report
2023/11/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/13

重要事件披露

Form 8-K - Current report
2023/10/18

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]